PharmExec Blog

Moving On + Up

Barry Goldstein Thomas HughesDan McIntyre

Promotions and hires for September 26, 2008:

  • Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity
  • Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December
  • GlaxoSmithKline named Ellen Strahlman chief medical officer
  • Questcor Pharmaceuticals appointed Gary Sawka CFO
  • Encorium appointed David Ginsberg president and CEO
  • Wyeth named Daniel J. McIntyre vice president, corporate communications
  • Genesis Pharmaceuticals appointed John Yang Wang to its board of directors
  • Zosano Pharma appointed Gail Schulze chair and CEO
  • Lilly named John Lechleiter its board of directors chairman
  • Merz Pharmaceuticals named Jack Britts president and CEO
  • Ferring Pharmaceuticals appointed Paul Korner, M.D., vice president, medical affairs
  • Zafgen appointed Thomas Hughes the company’s first CEO
This entry was posted in People and tagged , , , , , , , , , , , , , , , , , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Categories

  • Meta